Rare diseases
Investigational molecules
Locations
Study of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
BelgiumStudy on Ceralasertib and Trastuzumab Deruxtecan for Patients with Non-Small Cell Lung Cancer After Anti-PD-1/PD-L1 Therapy
AustriaStudy on the Effectiveness and Safety of Regorafenib for Patients with Metastatic Bone Sarcomas
FranceStudy of Adagloxad Simolenin/OBI-821, Capecitabine, and Pembrolizumab for Patients with High-Risk, Early-Stage Triple Negative Breast Cancer
PolandStudy on the Safety and Effectiveness of Durvalumab, Paclitaxel, and Drug Combinations for Patients with Metastatic Triple Negative Breast Cancer
PolandStudy Comparing Sentinel Node Policy with Current Staging Protocols in Early Stage Endometrial Cancer Using Patent Blue, Technetium (99mTc) Rheniumsulfide, and Indocyanine Green
FranceStudy on the Effects of Isoflurane and Propofol on Delirium in Intensive Care Patients on Mechanical Ventilation
FranceStudy on the Effects of Calcium Chloride and Bleomycin with Electroporation Techniques for Patients with Unresectable Pancreatic Cancer
PolandStudy on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma
GermanyStudy on Amiloride for Treating Nephrogenic Diabetes Insipidus in Bipolar Disorder Patients on Long-term Lithium Therapy
FranceStudy on the Safety and Immune Response of Meningococcal B Vaccines in Adults with Asplenia: Bexsero, Trumenba, and a Drug Combination
FranceStudy of Hydroxychloroquine Safety and Effectiveness in Patients with Early Systemic Sclerosis
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
